Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rawlings, S. L.
Right arrow Articles by Huber, P. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rawlings, S. L.
Right arrow Articles by Huber, P. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 2, Issue of January 12, 1996 pp. 869-877
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Analysis of the Binding of Xenopus Transcription Factor IIIA to Oocyte 5 S rRNA and to the 5 S rRNA Gene (*)

(Received for publication, June 21, 1995; and in revised form, September 6, 1995)

Stephen L. Rawlings (§) Gary D. Matt Paul W. Huber (¶)

From the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Binding of transcription factor IIIA (TFIIIA) to site-specific mutants of Xenopus oocyte 5 S rRNA has been used to identify important recognition elements in the molecule. The putative base triple G:U:A appears to determine the conformation of the loop E region whose integrity is especially important for binding of the factor. Proximal substitutions in helices IV and V indicate that the proper folding of loop E is also dependent on these structures. Mutations in helix V affect binding of TFIIIA to 5 S rRNA and to the gene similarly and provide evidence that zinc finger 5 makes sequence-specific contact through the major groove of both nucleic acids. Although fingers 1-3 are positioned along helix IV and loop D, mutations in this region, including those that disrupt the tetraloop or close the opening in the major groove of the helix created by the U:U mismatch, have no impact on binding. Substitutions made at stem-loop junctions in the arm of the RNA comprised of helix II-loop B-helix III display minor decreases in affinity for TFIIIA. Despite the alignment of the factor along nearly the entire length of 5 S rRNA, the essential elements for high affinity binding are limited to the central region of the molecule. Analysis of the corresponding mutations in the gene confirm that box C and the intermediate element provide the high affinity sites for binding of the factor to the DNA. Despite the small thermodynamic contribution made by contacts to box A, mutations made in this element can cause substantial changes in the orientation of the carboxyl-terminal fingers along the 5`-end of the internal control region.


INTRODUCTION

Transcription factor IIIA (TFIIIA) (^1)is a positive regulator of 5 S rRNA gene transcription(1) . Together with factors TFIIIB and TFIIIC, it forms an initiation complex on the intragenic promoter of these genes which directs transcription by RNA polymerase III(2) . In previtellogenic Xenopus oocytes the factor serves a second function, forming a complex with 5 S rRNA until this nucleic acid is used for the assembly of ribosomes in the later stages of oogenesis(3, 4) . Thus, TFIIIA has the distinctive ability to bind specifically to both the gene and its transcript. It is not clear whether the dual nucleic acid binding activity of TFIIIA is involved in the control of transcription of 5 S rRNA genes(4, 5) . Sequestering the factor into RNP particles may restrict the number of active transcription complexes and, thereby, abate synthesis of 5 S rRNA. In this case TFIIIA would be the mediator of an autoregulatory loop limiting the amount of 5 S rRNA that is ultimately synthesized during oogenesis.

In addition to being a potentially important aspect of the developmental regulation of 5 S rRNA synthesis, the binding of TFIIIA to both RNA and DNA is of considerable interest with respect to protein-nucleic acid recognition. TFIIIA possesses nine zinc finger domains (6) that mediate mutually exclusive interactions with the two nucleic acids(4) . The binding sites for the factor on the gene and on 5 S rRNA are similar(7, 8, 9) , which led to speculation that the protein associates with the two nucleic acids through common determinants. However, studies using truncated or mutated forms of TFIIIA have demonstrated that the nine zinc finger domains, while all contributing to some degree to DNA and RNA binding, are not functionally equivalent. Peptides containing the three amino-terminal finger domains bind to the gene with an affinity nearly equal to that of the intact factor(10, 11) . Moreover, variants of TFIIIA in which fingers 2 or 3 have been deleted or disrupted exhibit considerably reduced DNA binding affinity without a corresponding decrease in RNA binding(12, 13, 14) . Nuclease protection (11, 15, 16, 17) and missing nucleotide experiments (18) indicate that these three fingers bind in the major groove of the internal control region (ICR) from approximately nucleotide position 79 to 92. Both hydroxyl radical (16) and DNase I (15, 17) footprinting reveal a change in the orientation of the factor relative to the DNA helix in the vicinity of base pair 78 which likely signifies the exit of the protein from the major groove with finger 4 crossing the minor groove. The triplet of fingers 4-6 runs parallel to one side of the helix for nearly 20 base pairs. The factor then re-enters the major groove near base pair 60 and the three carboxyl-terminal fingers appear to be contiguously aligned in a manner similar to the amino-terminal fingers. The distinct orientation of the central three fingers on the gene may reflect their role as the primary mediators of RNA binding (12, 19) . A polypeptide comprised of zinc fingers 4-7 binds with high affinity to 5 S rRNA and deletion of two or more of these fingers from the factor significantly reduces binding to RNA. Thus, a model has emerged in which two subsets of fingers within TFIIIA confer differential specificity for binding of the factor to DNA (fingers 1-3) or RNA (fingers 4-6). Viewed in this way, the interactions of TFIIIA with the 5 S gene and 5 S rRNA are quite different. However, this oversimplification minimizes the contributions that the remaining fingers clearly make to the free energy of binding in both complexes (12, 13, 14) .

A variety of studies have used mutagenesis to define the interaction of TFIIIA with 5 S rRNA genes and 5 S rRNA(20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32) . The cumulative results of these studies establish that the binding site for TFIIIA on the 5 S rRNA gene is composed of three sequence elements which seemingly reflect the disposition of the protein along the DNA described above. As a consequence of disrupting sequence-specific interactions, mutations made in box C (bp 80-90) and the intermediate element (bp 67-72) have the most substantial effect on the binding of TFIIIA. On the other hand, binding of the factor to 5 S rRNA is most notably altered by changes in the higher order structure of the nucleic acid(12, 27, 33) . In this study we have examined the effects of point mutations made at critical locations within the structure of 5 S rRNA. Binding of TFIIIA to the corresponding mutations in the gene was also measured. The influence of most changes introduced into 5 S rRNA can be explained on the basis of the molecule's secondary structure. In particular, the integrity of loop E, which appears to be determined by a base triple interaction(34) , is especially important for binding of the factor. While the results presented here support earlier work establishing that the primary determinants of binding are located in nonhomologous regions of the two nucleic acids, helix V and its corresponding sequence in the gene, the intermediate element, appear to be common sites of recognition for the factor.


EXPERIMENTAL PROCEDURES

Preparation of TFIIIA and 5 S rRNA

The 7 S RNP particle of TFIIIA bound to 5 S rRNA was prepared from immature ovaries of Xenopus laevis (Nasco, Fort Atkinson, WI)(35) . TFIIIA was isolated from the RNP particle by the method of Smith et al.(36) with the following modifications. The 7 S particle was digested with RNase A (15 µg/mg particle) and RNase T(1) (200 units/mg particle) for 1 h at room temperature. The sample was loaded onto a BioRex-70 column equilibrated with buffer A (50 mM HEPES, pH 7.5, 5 mM MgCl(2), 1 mM DTT, 10 µM ZnCl(2), 20% glycerol) containing 0.1 M KCl. TFIIIA was eluted with buffer A containing 1 M KCl; one drop fractions were collected and stored at -80 °C. All steps were performed at room temperature and none of the buffers contained urea. Xenopus 5 S rRNA was prepared from the 7 S RNP particle by extraction with (NH(4))(2)SO(4)(37) followed by extraction with phenol. Escherichia coli 5 S rRNA was prepared from a crude fraction of ribosomes by methods described previously(38) . The tRNA was purchased from Boehringer Mannheim.

Construction and Cloning of a Xenopus Oocyte 5 S rRNA Gene Transcription Unit

A 153-bp fragment containing a T7 RNA polymerase promoter immediately upstream of a Xenopus oocyte 5 S rRNA gene was assembled from five complementary pairs of synthetic oligonucleotides (Fig. S1). Three of these double-stranded segments had protruding ends which were complementary to those of adjacent segments. One nmol of oligonucleotides a, b, B, c, C, d, D, and E were phosphorylated at the 5` termini using T4 polynucleotide kinase. Equal amounts of oligonucleotides A and e were added to the phosphorylated oligonucleotides and the mixture was annealed by slow cooling after heating to 85 °C for 2 min. The sample was incubated at 16 °C for 24 h in the presence of T4 DNA ligase (5 units) to seal nicks. The resulting 153-bp fragment was purified by electrophoresis in a 4% Nusieve GTG-agarose gel (FMC Bioproducts) and ligated through the EcoRI and BamHI restriction sites into pUC119 to generate the plasmid pT75S. The sequence of the cloned transcription unit was confirmed by sequencing.


Figure S1: Scheme 1.



In Vitro Synthesis of 5 S rRNA

Transcription reactions were carried out with minor modification of reported procedures(39) . Reaction mixtures containing 0.5 µg/µl plasmid linearized with DraI in 40 mM TrisbulletHCl, pH 7.5, 6 mM MgCl(2), 10 mM DTT, 2 mM spermidine, 2 mM each of ATP, CTP, and UTP, 0.2 mM GTP, 10 µCi of [alpha-P]GTP, 0.2 unit/µl RNasin (Promega), and 5 units/µl T7 RNA polymerase (Epicentre Technologies) were incubated at 37 °C for 90 min. At the conclusion of the synthesis, RNase-free DNase I (1 unit) was added and the incubation continued for an additional 30 min. Full-length 5 S rRNA was purified by electrophoresis on 12% polyacrylamide gels containing 8 M urea and subsequently renatured as described previously(40) . The sequence of the wild-type transcript was determined using enzymatic sequencing methods to establish that authentic full-length 5 S rRNA had been made.

Site-directed Mutagenesis

Oligonucleotide-directed mutagenesis was performed according to the procedure described by Kunkel(41) . E. coli strain BW313 (dut,ung) was transformed with pT75S and superinfected with M13K07 to stimulate production and preferential packaging of single-stranded pT75S that was enriched with uridine. In each case a 5`-phosphorylated primer was annealed to 1 µg of the uridine-enriched template (20:1 molar ratio, respectively); the solution was then adjusted to 20 mM HEPES, pH 7.8, 2 mM DTT, 10 mM MgCl(2), 0.5 mM dATP, dGTP, dCTP, and TTP, and 0.8 mM ATP. Five units each of T7 DNA polymerase and T4 DNA ligase were added and the mixture was kept on ice for 15 min, followed by incubation at 25 °C for 5 min, and then at 37 °C for 2 h. One-fifth of the extension reaction was used to transform E. coli (DH5alpha). Mutants were identified by sequencing plasmids prepared from randomly selected colonies.

Binding Assays

Protein concentrations were determined by the method of Bradford (42) using bovine serum albumin as the standard. Plasmids were prepared by the method of Holmes and Quigley (43) with some modifications and were purified over two successive CsCl gradients. The concentration of all DNA samples used in the TFIIIA binding assays was determined by a fluorometric method (44) specific for DNA in order to eliminate interference from any trace contamination of residual RNA. Sonicated calf thymus DNA used as the standard for the fluorometric assays was prepared by treating the nucleic acid with ribonucleases T(1) and A, extracting several times with phenol and phenol/chloroform, and then dialyzing extensively. The concentrations of RNA samples were determined spectrophotometrically at 260 nm using an extinction coefficient of 22.2 (mg/ml) cm.

Quantitative DNase I footprinting experiments were carried out with plasmids linearized with EcoRI and end-labeled on the coding strand using Klenow fragment and [alpha-P]dATP in the presence of 0.5 mM ddTTP. The DNA was then digested with BamHI to generate the 153-bp fragment containing the oocyte 5 S rRNA gene which was purified by electrophoresis on 6% polyacrylamide gels(45) . The fragment was eluted from the excised gel slices, extracted twice with phenol, once with phenol:chloroform (1:1), twice with chloroform, and then precipitated with ethanol. The assay mixture for footprinting contained 20 mM HEPES, pH 7.5, 70 mM NH(4)Cl, 7 mM MgCl(2), 5 mM DTT, 10 µM ZnCl(2), 0.01% Nonidet P-40, 1.8 nM 5 S rDNA in the form of linearized plasmid, and the indicated concentration of TFIIIA. DNase protection experiments were performed as described earlier(24, 38) . The autoradiographs of the sequencing gels were scanned with a laser densitometer to quantitate the intensity of the bands. A minimum of three bands inside the protected region were used to measure the amount of DNA bound to TFIIIA and two bands outside the ICR were used to normalize each lane relative to one another. The binding activity of TFIIIA was determined from Scatchard plots; however, wild type plasmid was included in every series of binding assays as a control for the activity of each sample of protein. Data for each mutant acquired from the densitometer scan was used to determine a dissociation constant by nonlinear regression analysis using the program EZ-Fit(46) . Binding assays were performed in duplicate and repeated with a minimum of two different preparations of DNA.

Binding of TFIIIA to mutant 5 S RNAs was measured by a shift in the mobility of the RNA in nondenaturing 8% polyacrylamide gels run at room temperature at 100 V(38) . Binding assays were carried out in the same buffer used to measure binding of TFIIIA to the 5 S gene except for the addition of ribonuclease inhibitor (RNasin, Promega; 0.4 unit/µl) and acetylated bovine serum albumin (0.1 µg/µl). The binding reactions contained 1.5 nM 5 S rRNA (internally labeled with [alpha-P]GTP) and the indicated concentration of TFIIIA in a total volume of 10 µl. Samples were incubated at room temperature for 30 min and, after the addition of 0.5 µl of sample buffer (0.25% bromphenol blue, 0.25% xylene cyanol, and 60% sucrose), were loaded onto the gels. Autoradiographs were scanned with a laser densitometer and this binding data was also processed using the EZ-Fit program(46) . Binding assays were performed in duplicate with a minimum of two different preparations of RNA. Alternatively, binding of TFIIIA to mutant 5 S rRNAs was measured using the exchange reaction described by Andersen and Delihas(47) . In this case the incorporation of P-labeled wild type 5 S rRNA into 7 S RNP complex was measured in the presence of unlabeled mutant 5 S rRNA. The reactions contained 50 mM TrisbulletHCl, pH 7.5, 3 mM DTT, 15 µg/ml bovine serum albumin, 6.5 µM 7 S RNP particle, 1.3 nM internally labeled wild-type 5 S rRNA and increasing amounts of unlabeled, competitor mutant RNA in a volume of 20 µl. The exchange reaction comes to equilibrium within 30 min at 20 °C(47) ; in these assays the reactions were kept at room temperature for 2 h. The products of the exchange reaction were analyzed by electrophoresis on nondenaturing polyacrylamide gels. The amounts of bound and free wild type 5 S rRNA were determined either by excising individual bands from the gels and measuring the radioactivity by Cherenkov counting or by scanning autoradiographs with a densitometer. The competition binding data was analyzed using the program LIGAND(48) . This program is specifically designed for the analysis of data from competition binding assays. It uses an exact mathematical model of the ligand binding system and a weighted least squares algorithm for curve fitting.


RESULTS AND DISCUSSION

The Structure of 5 S rRNA and Sites of Mutagenesis

A total of 42 site-specific mutations were made in the X. laevis oocyte 5 S rRNA gene. In vitro transcription of these genes using a promoter for T7 RNA polymerase enabled us to measure binding of the factor to the corresponding 5 S rRNA molecules. The majority of mutants were single-nucleotide substitutions that were chosen with regard to the structure of the RNA molecule. Several mutations changed features of the secondary structure of the nucleic acid which could be expected to be utilized by the protein for recognition and binding, e.g. bulged nucleotides and mismatched nucleotide pairs. Other mutants tested the importance of sequence, e.g. the repeated pentanucleotide CCUGG that flanks the two sides of loop E. The substitutions are displayed on the secondary structure of 5S rRNA in Fig. 1.


Figure 1: The nucleic acid binding sites for TFIIIA. A, the secondary structure of 5 S rRNA and the sites of mutagenesis. The positions marked on the secondary structure of the RNA designate the locations of point mutations; boxes enclose multiple substitutions or deletions. Additional mutants that contain multiple changes are listed below the secondary structure. For a given mutant the first letter indicates the wild type nucleotide and the letter following the position number indicates its replacement. Delta denotes a deletion. The structure of loop E is that proposed by Wimberly et al.(34) based upon data from two-dimensional NMR spectroscopy. B, the ICR of the Xenopus oocyte 5 S rRNA gene. Nucleotides protected by TFIIIA from digestion with DNase I are designated by bars above or below the noncoding and coding strands, respectively, while sites hypersensitive to the nuclease in the presence of TFIIIA are marked by asterisks. The positions where the somatic and oocyte sequences differ are indicated by placing the somatic-specific nucleotides above the noncoding strand. Guanine residues important for binding TFIIIA, determined in methylation interference experiments(61) , are represented by boldface letters. The locations of box A, the intermediate element (I.E.), and box C are defined by brackets(23) .



The binding affinity of TFIIIA for the mutant 5 S rRNAs was measured by titrating a constant amount of internally labeled RNA with increasing amounts of the protein. Free and bound 5 S rRNA were separated by electrophoresis on nondenaturing polyacrylamide gels (Fig. 2). Autoradiographs of the gels were scanned with a laser densitometer and the integrated volumes of the individual bands entered into the program EZ-Fit (46) which generates binding isotherms (Fig. 3) and a value for the K(D) of the complex. In those instances where a mutation has an effect, the magnitude is small, being generally 3-fold or less. In an effort to minimize the problems of measuring such small differences, we used at least two different preparations of each RNA and performed each assay in duplicate. Thus, there is a minimum of four assays for each mutant. In each series of experiments the dissociation constants of the mutants are presented relative to that for wild type 5 S rRNA measured in the same experiment in order to control for any differences in the activity of TFIIIA from one series of assays to another. The dissociation constant measured here for the TFIIIAbullet5 S rRNA complex is 2 nM which is in good agreement with values reported elsewhere(49, 50) . In addition, we found no difference in the affinity of TFIIIA for 5 S rRNA synthesized in vitro and native 5 S rRNA purified from 7 S RNP particle.


Figure 2: Mobility shift gel assays for binding of TFIIIA to mutant 5 S rRNAs. Autoradiographs for a selection of mutants are presented. In each assay 1.5 nM 5 S rRNA internally labeled with [P]GTP was incubated with increasing amounts of TFIIIA. The nanomolar concentration of factor is given below each lane of the gel. The two dots on the autoradiograph for T76G mark the two conformations of this RNA; the upper form corresponds to the native conformation.




Figure 3: Binding isotherms derived from RNA mobility shift assays. Autoradiographs of the nondenaturing polyacrylamide gels were scanned with a laser densitometer to quantitate the intensity of the individual bands. Exposures were within the linear response range of the film. Curves were fit to the data by nonlinear regression analysis(46) . A: , wild type; , A56T; , T76G. B: , wild type; , T96A; , G70C.



The binding of TFIIIA to the 5 S rRNA variants was also measured in competition assays. The exchange of radiolabeled wild type 5 S rRNA into the native 7 S RNP particle was measured in the presence of increasing concentrations of each mutant. Samples were analyzed by electrophoresis followed by autoradiography. The competition binding data, likewise obtained by densitometry, were processed using the program LIGAND(48) . The relative dissociation constants measured in these assays were very similar to those determined in the direct binding assays, providing an independent determination of binding strength.

Quantitative DNase I footprinting was used to measure the binding of the factor to the mutant 5 S rRNA genes in the same conditions used above for assays with RNA. Autoradiographs of sequencing gels were scanned with a densitometer and binding isotherms were again constructed using the EZ-Fit program (Fig. 4). The value of the Hill number was not constrained, which resulted in nonhyberbolic binding curves giving the best fit to the data. Only a single molecule of TFIIIA binds to the 5 S rRNA gene(36, 51) ; however, sigmoidal binding isotherms for TFIIIA have been observed in other studies(35, 52) . In our experiments this behavior may reflect the limitations of the footprinting method to detect small amounts of complex at low concentrations of protein. The dissociation constant measured for TFIIIA and the oocyte gene in these experiments is 3 nM. The dissociation constants for each mutant relative to wild type are presented in Table 1.


Figure 4: Quantitative DNase I footprint assays for binding of TFIIIA to mutant 5 S rRNA genes. A, autoradiographs for a selection of assays is presented that exhibit quantitative and/or qualitative effects on the binding of TFIIIA. In each assay 1.8 nM 5 S rRNA gene was incubated with increasing amounts of TFIIIA. The number above each lane indicates the nanomolar concentration of protein. In each panel the coding strand is shown with numbers on the left indicating nucleotide positions determined by the Maxam-Gilbert reaction for guanosine. Lanes marked C represent untreated DNA. B and C, binding isotherms derived from footprint titrations are presented for selected mutants. Autoradiographs of the sequencing gels were scanned with a densitometer to quantitate the intensity of individual bands at each concentration of TFIIIA. Curves were fit to the data by nonlinear regression analysis(46) . B: , wild type; bullet, DeltaA; circle, G81C,C95G. C: , wild type; bullet, A56T; (circle) T55C.





Helix IV-Loop D

There is accumulating evidence that specific features of secondary structure such as bulged nucleotides, non-Watson-Crick or mismatched base pairs, and base triples are important for the recognition of RNA by proteins(53, 54) . These elements can distort the usual A conformation of RNA helices, making the major groove accessible to proteins. Helix IV contains a U:U mismatch and a bulged adenosine flanked by a G:U pair that could be potentially utilized by TFIIIA. Experiments with chemical and enzymatic probes indicate that the bulged nucleotide at position 83 is external to helix IV, as are the other bulged nucleotides at positions 49, 50, and 63(8, 55) . Additionally, the metal complex Rh(phen)(2)(phi), which targets widened major grooves in RNA helices such as occurs at base triples and mismatched pairs, does not cleave at A(56) . This demonstrates that the bulged nucleotide is not involved in a base triple interaction with the adjacent G:U pair, but rather is in accord with the nucleoside being external to the helix. Baudin and Romaniuk (28) have shown that deletion of any of the bulged residues in Xenopus oocyte 5 S rRNA has no effect on the binding of TFIIIA. We also observe no appreciable effect upon deletion of A or substitution by G or C. However, a transversion to U at position 83 results in a 2-fold increase in the affinity of TFIIIA for the RNA.

The N3 positions of both U and U do not react with CMCT(8, 55) , suggesting a 2-carbonyl-N3, 4-carbonyl-N3 mismatched pair between these two bases. Cleavage by Rh(phen)(2)(phi) at positions U and G establishes that the major groove is accessible at the site of this mismatch(56) . Mutations that convert this site to either a Watson-Crick pair (U96A) or a wobble pair (U96G) have no effect on the binding of TFIIIA; however, cleavage by the rhodium probe is eliminated by these substitutions, indicating that the helix now approximates a canonical A-type conformation with a major groove that is inaccessible to the metal complex. Inversion of the G:C pair that flanks the U:U mismatch to C:G has no influence on binding of the factor, despite having some subtle effect on the geometry of the helix(56) . Substitution of C by G, which creates a second mismatch adjacent to the U:U pair and should have an appreciable effect on the structure of helix IV, also binds TFIIIA with wild type affinity. The only single nucleotide substitution that we have made in helix IV that has a notable effect on binding is proximal to loop E at C. A transversion to G, which generates a G:G mismatch, increases the K(D) 3-fold relative to wild type; however, a transition to U, which generates a G:U wobble pair in place of G:C, does not change binding affinity.

Loop D of Xenopus 5 S rRNA belongs to the family of tetranucleotide loops having the consensus sequence GNRA(57) . Structures of these loops determined by NMR spectroscopy reveal that their exceptional stability is a consequence of base pairing between the first and fourth bases in the loop, stacking of the bases in the loop, and putative base-phosphate hydrogen bonds(57, 58) . There are examples, particularly in ribosomal RNAs, where the GNRA loop is an essential component of a protein binding site(57) . However, substitutions made at position 86, which will enlarge the size of the loop D, or at position 87, which will eliminate the stabilizing hydrogen bonds between the first and fourth positions of the tetraloop, do not alter binding of TFIIIA.

Numerous chemical and enzymatic protection experiments indicate that TFIIIA is in close proximity to nucleotides within the helix IV-loop D region of 5 S rRNA(7, 8, 9, 49, 50, 59) . Nonetheless, we do not detect any significant thermodynamic contributions to binding in this region of the RNA upon making substitutions that will, in most cases, change local secondary structure in addition to sequence. The fortuitous increase in affinity seen with A83U does indicate that the protein is contiguous with this segment of the nucleic acid. However, our results are in accord with those from experiments in which helix IV was disrupted by block mutations or was truncated without appreciable decreases in binding TFIIIA(30, 60) . The mutation C79G, however, does decrease TFIIIA binding. This substitution creates two adjacent mismatched pairs proximal to loop E and may express its influence on binding through the latter structure (see later).

The binding of the factor to the corresponding mutations in the 5 S rRNA gene clearly establishes not only the differences between the two TFIIIA-nucleic acid complexes, but also the importance of bp 81-96 (box C) for binding to the DNA. Whereas the deletion of A has no impact on the binding of TFIIIA to 5 S rRNA, there is a significant 3.5-fold decrease in binding to the equivalent mutation in the DNA. Moreover, substitutions made at this position affect RNA and DNA binding differently. This position is not important for factor binding to the RNA; however, all three possible substitutions have a negative effect on binding of TFIIIA to the gene. Mutations at G and G which are silent in 5 S rRNA, likewise, have a pronounced influence on binding of the factor to the DNA. Notably, at the former position a transversion to C markedly effects binding while a transition to A is well tolerated, suggesting contact occurs through the N7 position of the purine. These latter guanine residues are among those positions along the ICR identified in methylation interference experiments(61) . The double mutant G81C,C95G, which simply inverts a base pair in helix IV, has little impact on binding of the factor to 5 S rRNA; however, it has a very marked effect on binding to the gene. This is most likely due to the change at residue 81, since the single mutation, G81C, has already been shown to significantly decrease binding of TFIIIA to the gene(23) . Zinc fingers 1 through 3 associate with box C of the ICR (11, 15, 16, 17, 18) and the helix IV-loop D region of 5 S rRNA(12) . The effects of mutations characterized here support previous data that this subset of fingers is of primary importance in mediating binding to DNA and makes only a small contribution to binding to 5 S rRNA(10, 12, 19, 62) .

Loop E

In ``missing nucleoside'' experiments we determined that loop E provides a critical structure for recognition and binding of TFIIIA to 5 S rRNA(9) . Studies with the structural probe Rh(phen)(2)(phi) demonstrated that loop E possesses a helical structure, due to base stacking interactions, with an opened major groove(56) . The conformation of a 27-nucleotide duplex which represents loop E has been determined by NMR spectroscopy (34) and reveals that this domain is comprised of several non-Watson-Crick pairings as well as a reverse-Hoogsteen pair forming a base triple with G (Fig. 1A). The structure, which closely resembles an A-form helix, is stabilized by significant base-stacking interactions and, perhaps, interstrand hydrogen bonding. Of the single nucleotide mutants tested in the present experiments, those in loop E have the greatest negative effect on binding of TFIIIA to the RNA.

In particular, the three nucleotides (G, U, and A) of the putative base-triple comprise an important element for recognition by TFIIIA. The conversion of the reverse-Hoogsteen A:U pair to a G:U pair (mutant A100G) has a modest influence on binding; however, a change to a C:U mismatch (mutant A100C) has a much more pronounced effect. Alternatively, when the Hoogsteen pair is disrupted by a substitution at U, the consequences are far more acute; quantitatively, the 9-fold effect of the mutant U76G is significantly greater than the many block mutations that have been used to characterize the TFIIIAbullet5 S rRNA complex(31) . The greater impact of a substitution at nucleotide 76 relative to its partner at 100 may reflect the fact that the former is also paired to G in the base triple and the latter is not. The U76G mutation engenders an alternative conformation in 5 S rRNA that is in equilibrium with the wild-type structure and this accounts for the exceptionally large effect on binding of the protein. The two forms are resolved on the nondenaturing polyacrylamide gels used for the binding assay (Fig. 2) with the alternative structure migrating ahead of the wild-type conformation. Although the two conformations are in equilibrium, their distinct mobility suggests that the global higher-order structures of the two forms are considerably different. The identity elements in 5 S rRNA for ribosomal protein L5 are confined to the hairpin structure composed of helix III-loop C. No mutations in the helix IV-loop E-helix V arm, including the quadruple mutation G70C, G71C,G81C,G82C, alter binding of L5; the only exception is U76G which has a greatly reduced affinity for L5. (^2)These results indicate that structural changes in U76G occur in regions of the RNA distal to the site of the mutation. In ``missing nucleoside'' experiments removal of U had the most deleterious impact on binding of TFIIIA to 5 S rRNA(9) . Additionally, U becomes cross-linked to G upon irradiation of 5 S rRNA with ultraviolet light (63) and the strong NOEs between these two bases (34) indicate that the helix is greatly overwound at the step between the Hoogsteen pair and the flanking G:A mismatched pair. This is borne out by the absence of cleavage by Rh(phen)(2)(phi) at this end of the loop(56) . McBryant et al.(64) have shown that deletion of the bulged G from 5 S rRNA causes a severe decrease in the binding of a four-fingered peptide derived from TFIIIA. This result further supports the contention that the base triple in loop E is either used directly by TFIIIA or creates a higher order structure essential for recognition.

The A:A mismatch pair immediately flanking the base triple structure is unexpectedly insensitive to mutagenesis; substitutions at either position do not disturb binding of TFIIIA. NMR studies (34) indicate that the ribose of A (and G) is predominantly C-endo and that this residue is in a reversed conformation, so that the direction of the two strands is parallel at this position. If substitutions at A change this local conformational perturbation, it does not influence the binding of TFIIIA. The structure generated at the Hoogsteen base pair, however, may be favored strongly enough to put any nucleotide at position 74 into a reversed conformation, maintaining this distortion in the helical structure of this strand.

The mutation C79G, which results in a 3-fold increase in K(D), creates consecutive mismatched pairs in helix IV, whereas conversion to a G:U wobble pair (C79T) has no effect. The consequence of the former substitution may be direct; however, it is equally possible that this disruption in the structure of the helix propagates itself into loop E. Indeed, a quadruple mutant G70C,G71C,G81C,G82C that will alter the structures of both helices IV and V binds TFIIIA with an affinity comparable to E. coli 5 S rRNA. This result attests to the importance of this arm of the molecule for high affinity binding and at the same time provides evidence that the intricate structure of loop E is critically dependent on the integrity of the flanking stem structures.

None of the mutations corresponding to the loop E region has an effect on the binding of TFIIIA to the 5 S rRNA gene, indicating again that the primary determinants for binding to the two nucleic acids are different.

Helix V

Disruption of this helix by block substitutions can increase the dissociation constant of the complex up to 3-fold; however, in most cases a second mutation that restores a base paired helical structure, but not the wild type sequence, can restore the binding affinity(30) . These results indicate that recognition occurs primarily through the higher order structure of the helix. Interestingly, we find that a transition at position 70 (G70A), which results in an A:C pair in helix V, is well tolerated by TFIIIA. An A:C pair, in which the imino nitrogen of adenine is protonated, has been shown to fit quite well into an A-form RNA double helix with virtually no distortion of the backbone(65) . The geometry of this non-Watson-Crick pair is similar to a G:U base pair (65) and, indeed, we find that conversion to a G:U pair (C105T) at this position of helix V also has no detrimental effect on binding. The transversion mutant G70C, however, produces a 3-fold increase in K(D). The magnitude of the effect of this point mutation equals or exceeds those of block mutants designed to disrupt the entire helix, suggesting that G70C, rather than simply disrupting the secondary structure of the helix, removes an important site for a sequence-specific contact with the protein. The fact that substitution by adenosine (G70A) has no effect supports this contention and provides evidence that contact at position 70 could occur through the N7 position of the purine base.

Methylation interference experiments indicate that G is also a critical contact point in the gene (61) . The consequences of substitutions made at this position are similar for both the RNA and DNA, indicating that this could be a common site of recognition shared between the two nucleic acids. A transition to A has no effect on the binding of TFIIIA to either nucleic acid, while transversion to C causes a decrease for both. The slightly greater effect of G70C on binding of the factor to RNA relative to DNA can be explained by the pyrimidine:pyrimidine apposition resulting in the former. Various mapping experiments indicate that finger 5 is contiguous to base pairs centered around position 70 both in the gene (11, 13, 15, 16, 18) and 5 S rRNA(19, 64) . Results from interference (61) and missing contact (18) experiments as well as the differences noted here between transition and transversion mutations all point to an interaction at this site through the major groove (possibly at the N7 of the purine) of both nucleic acids. Zinc fingers 4-6 of TFIIIA run parallel to the helical axis of the DNA, rather than following the trajectory of the major groove(15, 18) . Although finger 5 appears to bind through the major groove of the DNA, missing nucleoside experiments indicate that its orientation relative to the helix is different from the other major groove fingers, i.e. fingers 1-3 and 7-9(18) . This distinct alignment could reflect the fact that this finger may also be required to penetrate the less sterically accessible major groove of an A-form RNA helix. Thus, contacts to the nucleic acids may occur through amino acid side chains of the beta-sheet or tip region rather than the residues of the alpha-helix that dominate the interactions seen in the Zif 268(66) , GLI(67) , and Tramtrack (68) co-crystal structures. In this instance it is relevant that the structure of the DNA helix at the binding site for individual zinc finger domains frequently has a deep, but wide, major groove that can be characterized as intermediate between canonical A and B conformations(67, 69) . We have shown that the helical structure of the Xenopus 5 S rRNA gene is highly polymorphic, containing elements with A-like conformation(38, 70) . This feature in the structure of the DNA may also explain how the protein could make an equivalent contact to sites on both DNA and RNA.

Loop A

A model for oocyte 5 S rRNA based on chemical reactivity data has helices II and V nearly co-axial; this orientation is dependent on a triple interaction among nucleotides A, G, and U(71) . This model has been tested by an exhaustive set of mutations in loop A which show that substitutions that decrease the flexibility of this ``hinge'' region often have a negative effect on the affinity of TFIIIA(27) . We have changed U to a C which can then form a Watson-Crick pair with G, extending helix V toward loop A. This change results in a 2-fold increase in K(D) which has been reported by Baudin et al.(27) . It is clear from their work that a specific three-dimensional structure, dictated by the hydrogen bonding pattern within loop A, is an essential recognition element for this interaction. Zinc fingers 4 and 6 are especially important for binding of TFIIIA to 5 S rRNA (12, 19) and appear to be positioned at loops E and A, respectively(64) . It has been proposed that these two fingers, unlike the others, extend across the minor groove of the ICR when the factor is bound to the gene(15, 17, 18) , reflecting their functional difference relative to the other fingers. The only portion of loop A that has corresponding nucleotides in the ICR are positions 65-67. There is no data from the many mutagenesis or chemical and enzymatic probing experiments that indicate these nucleotides are important for the binding of TFIIIA to the gene.

Helix II-Loop B-Helix III

This arm of 5 S rRNA encompasses the binding site for fingers 7-9 which make corresponding contacts to the box A element (bp 50-64) of the ICR. These three fingers are not essential for binding of the factor to either nucleic acid(12) . Although dispensable, these fingers still make thermodynamic contributions to the free energy of binding to both 5 S rRNA(19, 64) and the gene(13, 72) . Contacts made by TFIIIA to this region of the RNA appear to utilize the secondary structure of the nucleic acid. Disruption of helix II with block mutations lowers affinity for TFIIIA as much as 3-fold; restoration of duplex structure, but not sequence, with complimentary changes in the opposite strand returns binding to wild type affinity(30) . Likewise, point mutations at several positions in helix II lower binding of the factor(12) , but these effects can also be reversed by secondary mutations that restore Watson-Crick pairing. Linker (25, 29, 30) and point (12) mutations in the remaining domains of this arm (i.e. loop B, helix III, and loop C) have only small effects, if any, on the affinity of TFIIIA for 5 S rRNA. Of the mutants we have made in this arm of the RNA, many, including the deletion of the two bulged adenosine residues in helix III, have no impact on binding of TFIIIA. However, substitutions at positions 43/44, 53, and 56, which occur at stem-loop junctions, do have modest effects. These results are in accord with chemical and enzymatic protection data (8) which suggest that TFIIIA utilizes the accessible, widened major groove that is known to occur at stem-loop junctions in RNA(73) .

Similarly, the binding of TFIIIA to box A is not significantly influenced by point mutations made in this element. Both DNase I and hydroxyl radical footprinting experiments (74) as well as missing nucleoside experiments (18) demonstrate that TFIIIA is closely associated with this region of the ICR. In contrast, no essential contacts within box A were identified in chemical interference experiments(61) . Studies using polypeptides representing subsets of zinc fingers derived from TFIIIA have demonstrated that binding affinity is not strictly correlated with the loss of contacts made to this region of the ICR(72) . The interaction of fingers 7-9 with box A appears to be complex and it has been proposed that the free energy of binding may be counterbalanced by other processes such as bending of the DNA (72) or unfavorable interactions between certain finger domains (13) . The apparently small energetic contribution made by fingers 7-9 is well illustrated by mutations made at position 56. A transversion at this site from A (major oocyte) to C (trace oocyte) abolishes over one-third of the TFIIIA footprint, yielding a protection pattern similar to that found on the trace-oocyte gene (bp 62-94). We have measured a 2-fold decrease in binding for the A to C transversion made at this site. The alternative transversion, A56T, has even less effect on the affinity for TFIIIA; yet, this mutant also exhibits a footprint diminished by approximately 20 base pairs (Fig. 4). It is difficult to understand how the association between TFIIIA and box A can be maintained based upon such a small change in free energy. One possible explanation is that disruption of the contacts between the factor and the 5`-end of the ICR relieves some high energy structure induced in the protein and/or nucleic acid upon complex formation. Indeed, there is evidence that the 5 S rRNA gene is markedly bent in the presence, but not in the absence, of TFIIIA(75, 76) . Based upon this observation and the unusually short linker sequences that lead to and from finger 6, Berg (77) has offered a model of the complex in which fingers 1-5 and 7-9 form contacts on the 3` and 5` sides, respectively, of the bend that occurs at the binding site for finger 6. It is possible that mutations at position 56 disrupt the interaction of the three carboxyl-terminal fingers that bind the 5` end of the ICR, obviating the protein-dependent bending of the DNA which, in turn, would compensate energetically for the reduced binding surface in the mutant. Deletion mutants of TFIIIA missing fingers 7-9 generate DNase I footprints very similar to those of the two mutants at position 56 (72, 74) .

The 5 S rRNA gene possesses an unusual amount of polymorphism in its helical structure(38, 70, 78) . CD spectroscopy and topoisomer band shift experiments showed that, on average, the helix is moderately underwound(38) . Cleavage of duplex DNA by DNase I is sensitive to the dimensions of the minor groove, being dampened where the width becomes either larger or smaller than the mean 12-Å cross-strand spacing(79) . Digestion profiles of DNA generated with this nuclease, therefore, provide a measure of the local structural heterogeneity of the helix (80, 81) . Changes in the DNase I cleavage patterns of several mutants relative to the wild type gene exemplify the potential importance of sequence-generated conformation. For example, inverting the G:C pair at position 81 mitigates the strong cutting that normally occurs at this site, while changing T to C abolishes the internal hypersensitive site on the coding strand at position 51 (Fig. 4). Mapping experiments with metal complexes that bind to DNA on the basis of shape complementarity revealed distinct, localized openings in the major groove due to base pair tilt(70) . Modeling experiments, based upon data from the conformational mapping, indicated that an opened major groove which is also underwound (A-like in structure) provides the maximal amount of surface overlap between a zinc finger domain and the DNA. Subsequently, these structural features of the helix were observed in the co-crystal structures of two different zinc finger peptides bound to their cognate sequences(67) . Interactions, such van der Waals forces, resulting from surface complementarity between the opened major groove and the zinc finger domain could potentially contribute to the binding of TFIIIA to the 5 S rRNA gene and may account, in some part, for the apparent complexity of the interaction.

Conclusions

Mutations in helix IV and loop D have no appreciable effect on the binding of TFIIIA, despite evidence that the protein is closely associated with this region of the RNA(7, 8, 9, 12) . The regular A type conformation of helix IV should disallow contact through the major groove. The U:U mismatch does create an opening in the major groove(56) ; however, when it is closed by mutagenesis (T96G,T96A) there is no change in binding of the factor. These results indicate that fingers 1-3 are weakly associated with the RNA through contacts to the ribose-phosphate backbone and/or sites in the minor groove, an arrangement different from that in the DNA complex.

Zinc fingers 4-6 make the greatest contribution to RNA binding(12, 19) . The mutations made here in loop E have some of the largest effects measured on RNA binding and implicate the putative G:U:A base triple as a major recognition element for TFIIIA. Our results, however, cannot be used to conclude whether contacts with finger 4 occur through the major or minor groove of this structure. Finger 6 also contacts a loop structure (loop A) and substitutions at this site, likewise, have a considerable impact on binding of TFIIIA to the RNA (27) . Fingers 4 and 6 appear to be specifically designed for recognition of the unique geometries presented by loops E and A, explaining both their importance for binding of the factor to 5 S rRNA and their relatively subordinate interaction with the gene.

Helix V of 5 S rRNA corresponds to the intermediate element of the ICR. These are the respective binding sites for finger 5. The various mutations we have made at nucleotides 70 and 105 affect binding to RNA and DNA similarly and provide evidence that this finger makes comparable interactions through the major grooves of both nucleic acids .

The three carboxyl-terminal fingers of TFIIIA associate with the helix II-loop B-helix III region of 5 S rRNA or the corresponding box A element of the ICR. We find that only substitutions made at stem-loop junctions in this arm of 5 S rRNA have any detectable effect on binding and these are rather small. Likewise, these mutations have little effect on the affinity of TFIIIA for the gene; yet, as demonstrated by substitutions made at A, they can cause considerable disruptions between the 5`-end of the ICR and the carboxyl-terminal fingers of the factor. Thus, although the apparent thermodynamic contribution of these three fingers to binding is not large, these interactions are important for properly orienting the factor on the ICR.


FOOTNOTES

*
This work was supported by Grant GM38200 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Present address: Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033.

To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556. Tel.: 219-631-6042; Fax: 219-631-6652.

(^1)
The abbreviations used are: TFIIIA, B, C, transcription factors IIIA, IIIB, and IIIC, respectively; ICR, internal control region; RNP, ribonucleoprotein; Rh(phen)(2)(phi), bis(phenanthroline)(phenanthrenequinone diimine)rhodium(III); CMCT, 1-cyclohexyl-3-(2-morpholinoethyl)-carbodiimide metho-p-toluene sulfonate; bp, base pair(s); DTT, dithiothreitol.

(^2)
J. B. Scripture and P. W. Huber, unpublished results.


ACKNOWLEDGEMENTS

We are grateful to Dr. Elliott Rosen for oligonucleotides, Drs. James McLinden, Elliott Rosen, and Joseph O'Tousa for providing the necessary strains and plasmids for site-directed mutagenesis, and to members of our laboratory for critically reading the manuscript.


REFERENCES

  1. Engelke, D. R., Ng, S.-Y., Shastry, B. S., and Roeder, R. G. (1980) Cell 19, 717-728 [CrossRef][Medline] [Order article via Infotrieve]
  2. Lassar, A. B., Martin, P. L., and Roeder, R. G. (1983) Science 222, 740-748 [Abstract/Free Full Text]
  3. Picard, B., and Wegnez, M. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 241-245 [Abstract/Free Full Text]
  4. Pelham, H. R. B., and Brown, D. D. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 4170-4174 [Abstract/Free Full Text]
  5. Rollins, M. B., Del Rio, S., Galey, A. L., Setzer, D. R., and Andrews, M. T. (1993) Mol. Cell. Biol. 13, 4776-4783 [Abstract/Free Full Text]
  6. Miller, J., McLachlan, A. D., and Klug, A. (1985) EMBO J. 4, 1609-1614 [Medline] [Order article via Infotrieve]
  7. Huber, P. W., and Wool, I. G. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 1593-1597 [Abstract/Free Full Text]
  8. Christiansen, J., Brown, R. S., Sproat, B. S., and Garrett, R. A. (1987) EMBO J. 6, 453-460 [Medline] [Order article via Infotrieve]
  9. Darsillo, P., and Huber, P. W. (1991) J. Biol. Chem. 266, 21075-21082 [Abstract/Free Full Text]
  10. Liao, X., Clemens, K. R., Tennant, L., Wright, P. E., and Gottesfeld, J. M. (1992) J. Mol. Biol. 223, 857-871 [CrossRef][Medline] [Order article via Infotrieve]
  11. Hansen, P. K., Christensen, J. H., Nyborg, J., Lillelund, O., and Thøgersen, H. C. (1993) J. Mol. Biol. 233, 191-202 [CrossRef][Medline] [Order article via Infotrieve]
  12. Theunissen, O., Rudt, F., Guddat, U., Mentzel, H., and Pieler, T. (1992) Cell 71, 679-690 [CrossRef][Medline] [Order article via Infotrieve]
  13. Del Rio, S., Menezes, S. R., and Setzer, D. R. (1993) J. Mol. Biol. 233, 567-579 [CrossRef][Medline] [Order article via Infotrieve]
  14. Darby, M. K., and Joho, K. E. (1992) Mol. Cell. Biol. 12, 3155-3164 [Abstract/Free Full Text]
  15. Clemens, K. R., Liao, X., Wolf, V., Wright, P. E., and Gottesfeld, J. M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10822-10826 [Abstract/Free Full Text]
  16. Hayes, J. J., and Clemens, K. R. (1992) Biochemistry 31, 11600-11605 [CrossRef][Medline] [Order article via Infotrieve]
  17. Fairall, L., and Rhodes, D. (1992) Nucleic Acids Res. 20, 4727-4731 [Abstract/Free Full Text]
  18. Hayes, J. J., and Tullius, T. D. (1992) J. Mol. Biol. 227, 407-417 [CrossRef][Medline] [Order article via Infotrieve]
  19. Clemens, K. R., Wolf, V., McBryant, S. J., Zhang, P., Liao, X., Wright, P. E., and Gottesfeld, J. M. (1993) Science 260, 530-533 [Abstract/Free Full Text]
  20. Bogenhagen, D. F. (1985) J. Biol. Chem. 260, 6466-6471 [Abstract/Free Full Text]
  21. Pieler, T., Appel, B., Oei, S. L., Mentzel, H., and Erdmann, V. A. (1985) EMBO J. 4, 1847-1853 [Medline] [Order article via Infotrieve]
  22. Pieler, T., Oei, S.-L., Hamm, J., Engelke, U., and Erdmann, V. A. (1985) EMBO J. 4, 3751-3756 [Medline] [Order article via Infotrieve]
  23. Pieler, T., Hamm, J., and Roeder, R. G. (1987) Cell 48, 91-100 [CrossRef][Medline] [Order article via Infotrieve]
  24. McConkey, G. A., and Bogenhagen, D. F. (1987) Mol. Cell. Biol. 7, 486-494 [Abstract/Free Full Text]
  25. Sands, M. A., and Bogenhagen, D. F. (1987) Mol. Cell. Biol. 7, 3985-3993 [Abstract/Free Full Text]
  26. Majowski, K., Mentzel, H., and Pieler, T. (1987) EMBO J. 6, 3057-3063 [Medline] [Order article via Infotrieve]
  27. Baudin, F., Romaniuk, P. J., Romby, P., Brunel, C., Westhof, E., Ehresmann, B., and Ehresmann, C. (1991) J. Mol. Biol. 218, 69-81 [CrossRef][Medline] [Order article via Infotrieve]
  28. Baudin, F., and Romaniuk, P. J. (1989) Nucleic Acids Res. 17, 2043-2056 [Abstract/Free Full Text]
  29. Romaniuk, P. J. (1989) Biochemistry 28, 1388-1395 [CrossRef][Medline] [Order article via Infotrieve]
  30. You, Q., and Romaniuk, P. J. (1990) Nucleic Acids Res. 18, 5055-5062 [Abstract/Free Full Text]
  31. You, Q., Veldhoen, N., Baudin, F., and Romaniuk, P. J. (1991) Biochemistry 30, 2495-2500 [CrossRef][Medline] [Order article via Infotrieve]
  32. Veldhoen, N., You, Q., Setzer, D. R., and Romaniuk, P. J. (1994) Biochemistry 33, 7568-7575 [CrossRef][Medline] [Order article via Infotrieve]
  33. Romby, P., Baudin, F., Brunel, C., Leal de Stevenson, I., Westhof, E., Romaniuk, P. J., Ehresmann, C., and Ehresmann, B. (1990) Biochimie (Paris) 72, 437-452
  34. Wimberly, B., Varani, G., and Tinoco, I., Jr. (1993) Biochemistry 32, 1078-1087 [CrossRef][Medline] [Order article via Infotrieve]
  35. Hanas, J. S., Bogenhagen, D. F., and Wu, C.-W. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2142-2145 [Abstract/Free Full Text]
  36. Smith, D. R., Jackson, I. J., and Brown, D. D. (1984) Cell 37, 645-652 [CrossRef][Medline] [Order article via Infotrieve]
  37. Shang, Z., Windsor, W. T., Liao, Y.-D., and Wu, C.-W. (1988) Anal. Biochem. 168, 156-163 [CrossRef][Medline] [Order article via Infotrieve]
  38. Huber, P. W., Blobe, G. C., and Hartmann, K. M. (1991) J. Biol. Chem. 266, 3278-3286 [Abstract/Free Full Text]
  39. Milligan, J. F., Groebe, D. R., Witherell, G. W., and Uhlenbeck, O. C. (1987) Nucleic Acids Res. 15, 8783-8798 [Abstract/Free Full Text]
  40. Huber, P. W., and Wool, I. G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 322-326 [Abstract/Free Full Text]
  41. Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382 [Medline] [Order article via Infotrieve]
  42. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  43. Holmes, D. S., and Quigley, M. (1981) Anal. Biochem. 114, 193-197 [CrossRef][Medline] [Order article via Infotrieve]
  44. Erwin, B. G., Stoscheck, C. M., and Florini, J. R. (1981) Anal. Biochem. 110, 291-294 [CrossRef][Medline] [Order article via Infotrieve]
  45. Maxam, A. M., and Gilbert, W. (1980) Methods Enzymol. 65, 499-560 [Medline] [Order article via Infotrieve]
  46. Perrella, F. W. (1988) Anal. Biochem. 174, 437-447 [CrossRef][Medline] [Order article via Infotrieve]
  47. Andersen, J., and Delihas, N. (1986) J. Biol. Chem. 261, 2912-2917 [Abstract/Free Full Text]
  48. Munson, P. J. (1983) Methods Enzymol. 92, 543-576 [Medline] [Order article via Infotrieve]
  49. Romaniuk, P. J. (1985) Nucleic Acids Res. 13, 5369-5387 [Abstract/Free Full Text]
  50. Sands, M. S., and Bogenhagen, D. F. (1991) Nucleic Acids Res. 19, 1791-1796 [Abstract/Free Full Text]
  51. Romaniuk, P. J. (1990) J. Biol. Chem. 265, 17593-17600 [Abstract/Free Full Text]
  52. McConkey, G. A., and Bogenhagen, D. F. (1988) Genes & Dev. 2, 205-214
  53. Huber, P. W. (1993) FASEB J. 7, 1367-1375 [Abstract]
  54. Wyatt, J. R., and Tinoco, I., Jr. (1993) in The RNA World (Gesteland, R. F., and Atkins, J. F., eds) pp. 465-496, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  55. Romaniuk, P. J., Leal de Stevenson, I., Ehresmann, C., Romby, P., and Ehresmann, B. (1988) Nucleic Acids Res. 16, 2295-2312 [Abstract/Free Full Text]
  56. Chow, C. S., Hartmann, K. M., Rawlings, S. L., Huber, P. W., and Barton, J. K. (1992) Biochemistry 31, 3534-3542 [CrossRef][Medline] [Order article via Infotrieve]
  57. Heus, H. A., and Pardi, A. (1991) Science 253, 191-194 [Abstract/Free Full Text]
  58. Szewczak, A. A., Moore, P. B., Chan, Y.-L., and Wool, I. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9581-9585 [Abstract/Free Full Text]
  59. Pieler, T., and Erdmann, V. A. (1983) FEBS Lett. 157, 283-287 [CrossRef][Medline] [Order article via Infotrieve]
  60. Bogenhagen, D. F., and Sands, M. S. (1992) Nucleic Acids Res. 20, 2639-2645 [Abstract/Free Full Text]
  61. Sakonju, S., and Brown, D. D. (1982) Cell 31, 395-405 [CrossRef][Medline] [Order article via Infotrieve]
  62. Christensen, J. H., Hansen, P. K., Lillelund, O., and Thogersen, H. C. (1991) FEBS Lett. 281, 181-184 [CrossRef][Medline] [Order article via Infotrieve]
  63. Branch, A. D., Benenfeld, B. J., and Robertson, H. D. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 6590-6594 [Abstract/Free Full Text]
  64. McBryant, S. J., Veldhoen, N., Gedulin, B., Leresche, A., Foster, M. P., Wright, P. E., Romaniuk, P. J., and Gottesfeld, J. M. (1995) J. Mol. Biol. 248, 44-57 [CrossRef][Medline] [Order article via Infotrieve]
  65. Puglisi, J. D., Wyatt, J. R., and Tinoco, I., Jr. (1990) Biochemistry 29, 4215-4226 [CrossRef][Medline] [Order article via Infotrieve]
  66. Pavletich, N. P., and Pabo, C. O. (1991) Science 252, 809-817 [Abstract/Free Full Text]
  67. Pavletich, N. P., and Pabo, C. O. (1993) Science 261, 1701-1707 [Abstract/Free Full Text]
  68. Fairall, L., Schwabe, J. W. R., Chapman, L., Finch, J. T., and Rhodes, D. (1993) Nature 366, 483-487 [CrossRef][Medline] [Order article via Infotrieve]
  69. Nekludova, L., and Pabo, C. O. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 6948-6952 [Abstract/Free Full Text]
  70. Huber, P. W., Morii, T., Mei, H.-Y., and Barton, J. K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 10801-10805 [Abstract/Free Full Text]
  71. Westhof, E., Romby, P., Romaniuk, P. J., Ebel, J.-P., Ehresmann, C., and Ehresmann, B. (1989) J. Mol. Biol. 207, 417-431 [CrossRef][Medline] [Order article via Infotrieve]
  72. Clemens, K. R., Zhang, P., Liao, X., McBryant, S. J., Wright, P. E., and Gottesfeld, J. M. (1994) J. Mol. Biol. 244, 23-35 [CrossRef][Medline] [Order article via Infotrieve]
  73. Weeks, K. M., and Crothers, D. M. (1993) Science 261, 1574-1577 [Abstract/Free Full Text]
  74. Vrana, K. E., Churchill, M. E. A., Tullius, T. D., and Brown, D. D. (1988) Mol. Cell. Biol. 8, 1684-1696 [Abstract/Free Full Text]
  75. Bazett-Jones, D. P., and Brown, M. L. (1989) Mol. Cell. Biol. 9, 336-341 [Abstract/Free Full Text]
  76. Schroth, G. P., Cook, G. R., Bradbury, E. M., and Gottesfeld, J. M. (1989) Nature 340, 487-488 [CrossRef][Medline] [Order article via Infotrieve]
  77. Berg, J. M. (1990) Annu. Rev. Biophys. Biophys. Chem. 19, 405-421 [CrossRef][Medline] [Order article via Infotrieve]
  78. Fairall, L., Martin, S., and Rhodes, D. (1989) EMBO J. 8, 1809-1817 [Medline] [Order article via Infotrieve]
  79. Suck, D., Lahm, A., and Oefner, C. (1988) Nature 332, 464-468 [CrossRef][Medline] [Order article via Infotrieve]
  80. Drew, H. R., and Travers, A. A. (1984) Cell 37, 491-502 [CrossRef][Medline] [Order article via Infotrieve]
  81. Rhodes, D., and Klug, A. (1986) Cell 46, 123-132 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. Ghose, M. Malik, and P. W. Huber
Restricted Specificity of Xenopus TFIIIA for Transcription of Somatic 5S rRNA Genes
Mol. Cell. Biol., March 15, 2004; 24(6): 2467 - 2477.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. A. Cassiday and L. J. Maher III
Having it both ways: transcription factors that bind DNA and RNA
Nucleic Acids Res., October 1, 2002; 30(19): 4118 - 4126.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. Szyma, M. Z. Barciszewska, V. A. Erdmann, and J. Barciszewski
An Analysis of G-U Base Pair Occurrence in Eukaryotic 5S rRNAs
Mol. Biol. Evol., August 1, 2000; 17(8): 1194 - 1198.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rawlings, S. L.
Right arrow Articles by Huber, P. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rawlings, S. L.
Right arrow Articles by Huber, P. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement